Table 1 Baseline characteristics of the patients with later revascularizations vs patients without
Whole population | Indemn of revascularization | New revascularization | p | |
|---|---|---|---|---|
N | 477 | 436 | 41 | |
Sex (% men) | 56.8% | 55.4% | 71.4% | 0.051 |
Age (years) | 62 ± 9 | 61 ± 9 | 64 ± 9 | 0.062 |
Duration of diabetes (years) | 14 ± 10 | 14 ± 9 | 17 ± 10 | 0.050 |
HbA1c (%) | 8.7 ± 1.8% | 8.7 ± 1.8% | 8.6 ± 1.7% | 0.826 |
BMI (kg/m2) | 32.7 ± 6.1 | 32.6 ± 6.2 | 33.4 ± 5.5 | 0.439 |
Triglycerides (mg/dL, median, IQR) | 158 (112–226) | 159 (113–223) | 154 (106–290) | 0.810 |
HDL-cholesterol (mg/dL) | 44 ± 13 | 44 ± 14 | 42 ± 10 | 0.309 |
LDL-cholesterol (mg/dL) | 105 ± 43 | 105 ± 43 | 99 ± 38 | 0.422 |
Treated by a statin (%) | 65.2% | 64.1% | 76.2% | 0.122 |
Arterial hypertension (%) | 64.8% | 63.9% | 73.8% | 0.238 |
Smoking (%) | 23.1% | 21.4% | 40.5% | 0.011 |
Albumin Excretion Rate (mg/24H, median, IQR) | 15 (4–62) | 14 (4–47) | 53 (8–360) | 0.001 |
Estimated GFR (mL/min/1.73m2) | 82 ± 25 | 83 ± 24 | 72 ± 28 | 0.006 |
Macroangiopathy (%) | 31.4% | 27.8% | 69.0% | 0.000 |
Retinopathy (%) | 25.8% | 24.4% | 40.5% | 0.027 |
Diabetic kidney disease (%) | 43.8% | 41.4% | 69.0% | 0.001 |
Skin autofluorescence (AU) | 2.67 ± 0.64 | 2.64 ± 0.62 | 3.00 ± 0.73 | 0.000 |